McCarthy, Eoghan M <br/><br/>
Treatment of relapsing polychondritis in the era of biological agents.  [electronic resource] 

 -  Rheumatology international  Apr 2010 
 - 827-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1437-160X 
<br/><br/><label>Standard No.: </label>10.1007/s00296-009-1308-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antirheumatic Agents--therapeutic use<br/>Aortic Valve--drug effects<br/>Aortic Valve Insufficiency--drug therapy<br/>Azathioprine--therapeutic use<br/>C-Reactive Protein--metabolism<br/>Cardiac Surgical Procedures<br/>Collagen--immunology<br/>Hearing Loss, Sensorineural--etiology<br/>Humans<br/>Immunity, Cellular--drug effects<br/>Immunosuppressive Agents--therapeutic use<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Middle Aged<br/>Polychondritis, Relapsing--complications<br/>Rituximab<br/>Treatment Outcome